Literature DB >> 18203193

A unique case of fibrodysplasia ossificans progressiva with an ACVR1 mutation, G356D, other than the common mutation (R206H).

Hirokazu Furuya1, Koji Ikezoe, Lixiang Wang, Yasumasa Ohyagi, Kyoko Motomura, Naoki Fujii, Jun-Ichi Kira, Yasuyuki Fukumaki.   

Abstract

Fibrodysplasia ossificans progressiva (FOP) is a rare autosomal dominant congenital disease characterized by progressive heterotopic endochondral osteogenesis with great-toe malformations. A 617G > A (R206H) mutation of the activin A type 1 receptor gene (ACVR1) has been found in all previously reported patients with FOP. Thus, this is one of the most specific of all disease-associated mutations. We report here on a 62-year-old man with slowly progressive FOP and a novel mutation in ACVR1. He developed difficulty in moving his shoulder since age 10 years due to contraction of the shoulder joint. The symptoms progressed slowly, and he could not walk at age 36 years and was bedridden at 55 years. He also showed rigid spine, baldness, sensorineural hearing loss, and hypodactyly accompanied by abnormal ectopic ossification. Analysis of ACVR1 and its cDNA revealed that the patient is heterozygous for a mutation, 1067G > A (G356D). Typing of SNPs located in the approximately 0.5-Mb region spanning ACVR1 and its neighbor genes suggested that 1067G > A is a de novo mutation. These results give a clue to better understanding of FOP as well as of the mild clinical symptoms in the patient.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18203193     DOI: 10.1002/ajmg.a.32151

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  29 in total

1.  Osteogenic gene expression correlates with development of heterotopic ossification in war wounds.

Authors:  Korboi N Evans; Benjamin K Potter; Trevor S Brown; Thomas A Davis; Eric A Elster; Jonathan A Forsberg
Journal:  Clin Orthop Relat Res       Date:  2013-10-18       Impact factor: 4.176

2.  A novel ACVR1 mutation in the glycine/serine-rich domain found in the most benign case of a fibrodysplasia ossificans progressiva variant reported to date.

Authors:  Celia L Gregson; Peter Hollingworth; Martin Williams; Kirsten A Petrie; Alex N Bullock; Matthew A Brown; Jon H Tobias; James T Triffitt
Journal:  Bone       Date:  2010-10-29       Impact factor: 4.398

3.  Fibrodysplasia ossificans progressiva without characteristic skeletal anomalies.

Authors:  Hasan Ulusoy
Journal:  Rheumatol Int       Date:  2010-03-27       Impact factor: 2.631

4.  The phenotype and genotype of fibrodysplasia ossificans progressiva in China: a report of 72 cases.

Authors:  Wei Zhang; Keqin Zhang; Lige Song; Jing Pang; Hongxing Ma; Eileen M Shore; Frederick S Kaplan; Peijun Wang
Journal:  Bone       Date:  2013-09-17       Impact factor: 4.398

Review 5.  Fibrodysplasia ossificans progressiva: clinical course, genetic mutations and genotype-phenotype correlation.

Authors:  Irina Hüning; Gabriele Gillessen-Kaesbach
Journal:  Mol Syndromol       Date:  2014-08-07

Review 6.  Molecular and cellular mechanisms of heterotopic ossification.

Authors:  Diana M Ramirez; Melissa R Ramirez; Anthony M Reginato; Damian Medici
Journal:  Histol Histopathol       Date:  2014-05-05       Impact factor: 2.303

Review 7.  Fibrodysplasia ossificans progressiva: diagnosis, management, and therapeutic horizons.

Authors:  Robert J Pignolo; Eileen M Shore; Frederick S Kaplan
Journal:  Pediatr Endocrinol Rev       Date:  2013-06

8.  Classic and atypical fibrodysplasia ossificans progressiva (FOP) phenotypes are caused by mutations in the bone morphogenetic protein (BMP) type I receptor ACVR1.

Authors:  Frederick S Kaplan; Meiqi Xu; Petra Seemann; J Michael Connor; David L Glaser; Liam Carroll; Patricia Delai; Elisabeth Fastnacht-Urban; Stephen J Forman; Gabriele Gillessen-Kaesbach; Julie Hoover-Fong; Bernhard Köster; Richard M Pauli; William Reardon; Syed-Adeel Zaidi; Michael Zasloff; Rolf Morhart; Stefan Mundlos; Jay Groppe; Eileen M Shore
Journal:  Hum Mutat       Date:  2009-03       Impact factor: 4.878

9.  Dysregulation of local stem/progenitor cells as a common cellular mechanism for heterotopic ossification.

Authors:  Lixin Kan; Yijie Liu; Tammy L McGuire; Diana M Palila Berger; Rajeshwar B Awatramani; Susan M Dymecki; John A Kessler
Journal:  Stem Cells       Date:  2009-01       Impact factor: 6.277

10.  Rarely occurring mutation of ACVR1 gene in Moroccan patient with fibrodysplasia ossificans progressiva.

Authors:  Ilham Ratbi; Renata Bocciardi; Asmaa Regragui; Roberto Ravazzolo; Abdelaziz Sefiani
Journal:  Clin Rheumatol       Date:  2009-10-01       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.